Common name
2-acetamido-N-methyl-acetamide
IUPAC name
2-acetamido-N-methyl-acetamide
SMILES
CC(=O)NCC(=O)NC
Common name
2-acetamido-N-methyl-acetamide
IUPAC name
2-acetamido-N-methyl-acetamide
SMILES
CC(=O)NCC(=O)NC
INCHI
InChI=1S/C5H10N2O2/c1-4(8)7-3-5(9)6-2/h3H2,1-2H3,(H,6,9)(H,7,8)
FORMULA
C5H10N2O2
Common name
2-acetamido-N-methyl-acetamide
IUPAC name
2-acetamido-N-methyl-acetamide
Molecular weight
130.145
clogP
-0.634
clogS
-1.023
Frequency
0.0014
HBond Acceptor
2
HBond Donor
2
Total PolarSurface Area
58.2
Number of Rings
0
Rotatable Bond
2
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00100 | Remikiren |
|
Cardiovascular System; Agents Acting on the Renin-Angiotensin System; Renin-Inhibitors; | For the treatment of hypertension and heart failure. |
| FDBD00648 | Marimastat |
|
Enzyme Inhibitors; | For the treatment of various cancers. |
| FDBD00753 | Benzylpenicilloyl Polylysine |
|
Acetamides; | For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G). |
| FDBD01392 | Lacosamide |
|
Anticonvulsants; Nervous System; Antiepileptics; | Lacosamide is indicated for adjunctive therapy for partial onset seizures in patients with epilepsy over 17 years old. Injection is indicated for short term use when oral therapy is not feasible. |
4 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 1a7c_ligand_4_507.mol2 | 1a7c | 1 | -6.65 | CC(=O)NCC(=O)NCC | 10 |
| 1a7c_ligand_3_12.mol2 | 1a7c | 1 | -6.36 | N(C(=O)C)CC(=O)NC | 9 |
| 1bxq_ligand_5_3261.mol2 | 1bxq | 1 | -6.20 | CC(=O)NCC(=O)NCC | 10 |
| 3d91_ligand_5_3731.mol2 | 3d91 | 1 | -6.18 | CCNC(=O)CNC(=O)C | 10 |
| 2h65_ligand_4_611.mol2 | 2h65 | 1 | -6.14 | C(=O)(NCC)CNC(=O)C | 10 |
| 1ym4_ligand_5_700.mol2 | 1ym4 | 1 | -6.13 | N(C(=O)C)CC(=O)NCC | 10 |
680 ,
69
